Sanj K. Patel - 01 Sep 2024 Form 4 Insider Report for Kiniksa Pharmaceuticals International, plc (KNSA)

Role
CHAIRMAN & CEO, Director
Signature
/s/ Madelyn Zeylikman, Attorney-in-Fact
Issuer symbol
KNSA
Transactions as of
01 Sep 2024
Net transactions value
-$297,991
Form type
4
Filing time
04 Sep 2024, 20:55:36 UTC
Previous filing
25 Jul 2024
Next filing
08 Nov 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KNSA Class A Ordinary Share Options Exercise +16,474 +24% 84,126 01 Sep 2024 Direct F1
transaction KNSA Class A Ordinary Share Tax liability $213,038 -7,967 -9.5% $26.74 76,159 01 Sep 2024 Direct
transaction KNSA Class A Ordinary Share Options Exercise +6,569 +8.6% 82,728 02 Sep 2024 Direct F1
transaction KNSA Class A Ordinary Share Tax liability $84,953 -3,177 -3.8% $26.74 79,551 02 Sep 2024 Direct
holding KNSA Class A Ordinary Share 109,795 01 Sep 2024 Held by The Marina 2016 Irrevocable Trust, u/d/t June 23, 2016

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KNSA Restricted Share Unit Award $0 +24,950 $0.000000 24,950 01 Sep 2024 Class A Ordinary Share 24,950 Direct F1, F2
transaction KNSA Share Option Award $0 +129,750 $0.000000 129,750 01 Sep 2024 Class A Ordinary Share 129,750 $26.74 Direct F3
transaction KNSA Restricted Share Unit Options Exercise -9,992 -33% 19,983 01 Sep 2024 Class A Ordinary Share 9,992 Direct F1, F4
transaction KNSA Restricted Share Unit Options Exercise -6,482 -25% 19,443 01 Sep 2024 Class A Ordinary Share 6,482 Direct F1, F5
transaction KNSA Restricted Share Unit Options Exercise -6,569 -50% 6,569 02 Sep 2024 Class A Ordinary Share 6,569 Direct F1, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer.
F2 The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2024.
F3 The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is September 1, 2024.
F4 The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2022.
F5 The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2023.
F6 The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 2, 2021.